[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories (CRL)

Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,911,079
  • Shares Outstanding, K 48,168
  • Annual Sales, $ 4,015 M
  • Annual Income, $ -144,340 K
  • EBIT $ 576 M
  • EBITDA $ 1,144 M
  • 60-Month Beta 1.46
  • Price/Sales 2.19
  • Price/Cash Flow 8.31
  • Price/Book 2.98

Options Overview Details

View History
  • Implied Volatility 49.23% (-0.90%)
  • Historical Volatility 48.58%
  • IV Percentile 55%
  • IV Rank 42.63%
  • IV High 71.52% on 02/17/26
  • IV Low 32.66% on 09/03/25
  • Expected Move (DTE 28) 9.18 (4.96%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 1,328
  • Volume Avg (30-Day) 462
  • Put/Call OI Ratio 0.28
  • Today's Open Interest 9,585
  • Open Int (30-Day) 6,804
  • Expected Range 175.82 to 194.18

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.75
  • Number of Estimates 7
  • High Estimate $3.00
  • Low Estimate $2.69
  • Prior Year $3.12
  • Growth Rate Est. (year over year) -11.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
146.20 +26.54%
on 05/19/26
193.80 -4.54%
on 06/10/26
+35.07 (+23.39%)
since 05/18/26
3-Month
146.20 +26.54%
on 05/19/26
194.57 -4.92%
on 05/07/26
+27.89 (+17.75%)
since 03/18/26
52-Week
144.26 +28.24%
on 09/25/25
228.88 -19.17%
on 01/13/26
+39.71 (+27.33%)
since 06/18/25

Most Recent Stories

More News
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise

Collaboration supports Charles River’s strategic goals to build deeper client relationships to further modernize R&D through innovative technologies

CRL : 185.00 (+1.46%)
Stocks Mixed Ahead of FOMC Meeting Results

The S&P 500 Index ($SPX ) (SPY ) today is down -0.15%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.30%. June E-mini S&P futures (ESM26...

GOOGL : 368.03 (+1.17%)
AAPL : 298.01 (+0.70%)
ADI : 434.46 (+4.83%)
FDXF : 162.85 (+0.59%)
TSLA : 400.49 (+1.04%)
JBL : 371.88 (-0.83%)
AMD : 537.37 (+4.86%)
CME : 246.38 (-2.44%)
SPY : 746.74 (+1.04%)
META : 577.22 (+1.70%)
MU : 1,133.99 (+8.70%)
QQQ : 740.62 (+2.51%)
Stocks Supported by Chip Stock Strength and Strong US Retail Sales

The S&P 500 Index ($SPX ) (SPY ) today is up +0.23%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.74%. June E-mini S&P futures (ESM26...

AMAT : 617.11 (+4.08%)
AVGO : 411.35 (+4.70%)
VZ : 45.37 (-1.03%)
REXR : 33.12 (+2.00%)
$IUXX : 30,406.19 (unch)
WNC : 11.36 (+5.19%)
ASML : 1,929.68 (+3.31%)
ZNU26 : 109-105 (-0.27%)
ESU26 : 7,556.25s (-0.19%)
T : 22.01 (-1.92%)
QCOM : 226.11 (+6.17%)
JBL : 371.88 (-0.83%)
1 S&P 500 Stock on Our Buy List and 2 We Brush Off

1 S&P 500 Stock on Our Buy List and 2 We Brush Off

HCA : 375.17 (-3.35%)
CRL : 185.00 (+1.46%)
CBRE : 131.55 (+0.58%)
Charles River Laboratories to Present at William Blair and Jefferies Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the William Blair 46 th Annual Growth Stock Conference on Tuesday, June 2 nd ...

CRL : 185.00 (+1.46%)
Are Wall Street Analysts Bullish on Charles River Laboratories Stock?

Charles River Laboratories has underperformed the S&P 500 over the past 52 weeks, yet Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.

XLV : 149.40 (-0.87%)
$SPX : 7,500.58 (unch)
CRL : 185.00 (+1.46%)
The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call

CRL : 185.00 (+1.46%)
NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

NEO : 11.13 (+7.23%)
CRL : 185.00 (+1.46%)
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

Partnership showcases a forward- looking collaboration model that highlights advanced testing expertise

CRL : 185.00 (+1.46%)
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

Charles River Laboratories International, Inc. (NYSE: CRL) today announced continued momentum in its digital pathology platform, delivering an end-to-end, AI-enabled workflow that significantly accelerates...

CRL : 185.00 (+1.46%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 191.02
2nd Resistance Point 188.60
1st Resistance Point 186.80
Last Price 185.00
1st Support Level 182.58
2nd Support Level 180.16
3rd Support Level 178.36

See More

52-Week High 228.88
Fibonacci 61.8% 196.56
Fibonacci 50% 186.57
Last Price 185.00
Fibonacci 38.2% 176.58
52-Week Low 144.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.